Alveolar rhabdomyosarcoma
From Wikipedia, the free encyclopedia
| Alveolar rhabdomyosarcoma | |
|---|---|
| Classification and external resources | |
| ICD-O: | M8920/3 |
| MeSH | D018232 |
Alveolar rhabdomyosarcoma is a type of rhabdomyosarcoma characterized by its appearance, which is similar to the alveoli of the lungs.
It can be associated with a fusion protein between PAX3 and FKHR (now known as FOXO1).[1][2]
It can also be associated with PAX7-FKHR.[3][4]
[edit] References
- ^ Fredericks WJ, Galili N, Mukhopadhyay S, et al. (March 1995). "The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3". Mol. Cell. Biol. 15 (3): 1522–35. PMC 230376. PMID 7862145. http://mcb.asm.org/cgi/pmidlookup?view=long&pmid=7862145.
- ^ Mercado GE, Xia SJ, Zhang C, et al. (June 2008). "Identification of PAX3-FKHR-regulated genes differentially expressed between alveolar and embryonal rhabdomyosarcoma: focus on MYCN as a biologically relevant target". Genes Chromosomes Cancer 47 (6): 510–20. doi:10.1002/gcc.20554. PMID 18335505.
- ^ Mercado GE, Barr FG (February 2007). "Fusions involving PAX and FOX genes in the molecular pathogenesis of alveolar rhabdomyosarcoma: recent advances". Curr. Mol. Med. 7 (1): 47–61. doi:10.2174/156652407779940440. PMID 17311532. http://www.bentham-direct.org/pages/content.php?CMM/2007/00000007/00000001/0005M.SGM.
- ^ Laé M, Ahn EH, Mercado GE, et al. (June 2007). "Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas". J. Pathol. 212 (2): 143–51. doi:10.1002/path.2170. PMID 17471488.
[edit] See also
|
||||||||||||||||||||||||||||||||||||
| This oncology article is a stub. You can help Wikipedia by expanding it. |